Drugs / RG3421
last change Sep 2009 re-read 3 minutes ago

RG3421

Developed for
psoriasis
Investigated by
Hoffmann-La Roche

Trials 1

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00504270 Jul 2007 → Sep 2009 psoriasis Hoffmann-La Roche Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as RG3421 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00504270 ↗